This article has been updated to include comments from Xifin Executive Chairman and CEO Lale White.

NEW YORK (360Dx) – New Medicare reimbursement rates for lab tests implemented at the start of the year under the Protecting Access to Medicare Act could lead to billions in excess Medicare payments to laboratories in the years ahead, according to a new report from the US Government Accountability Office.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.